Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Bonds: Other Debt, New, 2019 Q4

CITADEL ADVISORS LLC historic quarter change: USA Bonds: Other Debt, New

In other debt filed by principal amount (debentures, bonds) (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 884 positions, added to 1,270, reduced 1,104 and sold out of 996.

  • Q4 2019: Stock MEDICINES CO; Country of operation —; Class Bond; Principal before $0.
  • Q4 2019: Stock OMEROS CORP; Country of operation —; Class Bond; Principal before $0.
  • Q4 2019: Stock KARYOPHARM THERAPEUTICS INC; Country of operation —; Class Bond; Principal before $0.
  • Q4 2019: Stock BENEFITFOCUS INC; Country of operation —; Class Bond; Principal before $0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q4 2019MEDICINES CO
CUSIP 584688AJ4
—Bond$0$18,700,000+18,700,000$0$63,920+$63,9202020-02-14
Q4 2019OMEROS CORP
CUSIP 682143AE2
—Bond$0$55,700,000+55,700,000$0$54,280+$54,2802020-02-14
Q4 2019KARYOPHARM THERAPEUTICS INC
CUSIP 48576UAA4
—Bond$0$29,750,000+29,750,000$0$42,722+$42,7222020-02-14
Q4 2019BENEFITFOCUS INC
CUSIP 08180DAB2
—Bond$0$32,500,000+32,500,000$0$28,214+$28,2142020-02-14
Q4 2019INVACARE CORP
CUSIP 461203AJ0
—Bond$0$25,500,000+25,500,000$0$23,473+$23,4732020-02-14
Q4 2019TILRAY INC
CUSIP 88688TAB6
—Bond$0$32,990,000+32,990,000$0$17,593+$17,5932020-02-14
Q4 2019IQIYI INC
CUSIP 46267XAB4
—Bond$0$15,270,000+15,270,000$0$16,928+$16,9282020-02-14
Q4 2019NUANCE COMMUNICATIONS INC
CUSIP 67020YAG5
—Bond$0$9,000,000+9,000,000$0$9,530+$9,5302020-02-14
Q4 2019VERASTEM INC
CUSIP 92337CAB0
—Bond$0$10,200,000+10,200,000$0$8,928+$8,9282020-02-14
Q4 2019AIR TRANSPORT SERVICES GRP I
CUSIP 00922RAB1
—Bond$0$9,000,000+9,000,000$0$8,782+$8,7822020-02-14
Q4 2019OKTA INC
CUSIP 679295AB1
—Bond$0$3,591,000+3,591,000$0$8,726+$8,7262020-02-14
Q4 2019JAZZ INVESTMENTS I LTD
CUSIP 472145AB7
—Bond$0$6,500,000+6,500,000$0$6,690+$6,6902020-02-14
Q4 2019TERADYNE INC
CUSIP 880770AG7
—Bond$0$2,500,000+2,500,000$0$5,492+$5,4922020-02-14
Q4 2019THERAVANCE INC
CUSIP 88338TAB0
—Bond$0$4,000,000+4,000,000$0$4,025+$4,0252020-02-14
Q4 2019SCORPIO TANKERS INC
CUSIP 80918TAB5
—Bond$0$2,000,000+2,000,000$0$2,459+$2,4592020-02-14
Q4 2019NUANCE COMMUNICATIONS INC
CUSIP 67020YAK6
—Bond$0$2,000,000+2,000,000$0$2,015+$2,0152020-02-14
Q4 2019ARES CAP CORP
CUSIP 04010LAT0
—Bond$0$1,000,000+1,000,000$0$1,035+$1,0352020-02-14
Q4 2019OIL STS INTL INC
CUSIP 678026AH8
—Bond$0$1,000,000+1,000,000$0$898+$8982020-02-14
Q4 2019INTELSAT S A
CUSIP 45790VAB6
—Bond$0$1,000,000+1,000,000$0$666+$6662020-02-14